Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial

AK Burnett, Robert Hills, Donald Milligan, L Kjeldsen, J Kell, NH Russell, JAL Yin, A Hunter, AH Goldstone, Keith Wheatley

Research output: Contribution to journal › Article

434 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences